secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2025-10-01T23:59:59+00:00
Accession:  0001398733-25-000020
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics furnishes October 2025 investor presentation
-------------------------------------------------------------------

- Presentation includes company overview, pipeline, and strategy; no new financial results disclosed.
- Filed under Regulation FD as a routine investor presentation for institutional meetings.
- No specific material changes or guidance updates noted in the exhibit text provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000139873325000020/0001398733-25-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000139873325000020/aqst-20251001.htm
  HTML page:      https://secwatch.observer/filing/0001398733-25-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer